Related Experiment Video
Updated: Jan 9, 2026

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Published on: June 25, 2018
Antimony induces oxidative stress to impair enteroendocrine cells and disrupt glucose homeostasis
Lanfei Jin1, Longtao Zhu2, Chengdong Wu3
1Department of General Surgery, Sir Run Run Shaw Hospital and Institute of Environmental Medicine, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310016, China; Zhejiang Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
Abstract:
Enteroendocrine L and K cells play pivotal roles in glucose homeostasis through producing the key intestinal hormones GLP-1 and GIP, respectively. Antimony (Sb) exposure has been associated with an elevated risk of diabetes, but the molecular mechanisms involved remain poorly understood. In this study, we identified a significant inverse correlation between urinary Sb levels and clinical glycemic markers. We further demonstrated that Sb exposure impairs the function of enteroendocrine L and K cells, leading to reduced production of GLP-1 and GIP, thereby disrupting systemic glucose regulation. Mechanistically, Sb-induced oxidative stress modulates crucial signaling pathways, inhibiting GLP-1 expression and suppressing GIP expression via downregulation of essential transcription factors. These findings provide novel insights into the pathogenic link between environmental Sb exposure and metabolic dysfunction, offering a mechanistic basis for epidemiological associations of Sb with diabetes.
Related Concept Videos
Sulfur Assimilation
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Psychoneuroimmunology: Diabetes and Cancer
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Sulfonylureas

